Description
ESO26 was established from a primary tumour located in the gastroesophageal junction and distal oesophagus of a 56 year-old Caucasian male in 2000 involving lymph nodes and distant metastases. ESO26 was found to be tumourigenic in female NMRI nude mice or NOD-SCID mice.
Adherent Suspension
Suspension
Suggested Medium
RPMI-1640 + 2mM Glutamine + 10% Foetal Bovine Serum (FBS)
Quality Control
ESO26 Cell Line was tested and found to be free of mycoplasma, bacterial, viruses, and other toxins. All cells were above 95% viability before freezing.
Tissue
Gastroesophageal junction and distal oesophagus
Morphology
Large spherical clumps of cells loosely adherent to the plastic
Shippment
ESO26 Cell Line will be shipped using dry ice.
Storage
Store the cell lines in liquid nitrogen vapor (less than -130°C)
Warranty
ESO26 Cell Line is for research use only
